To further guide and standardize the use of real-world evidence in drug R&D and review, and ensure the quality and efficiency of drug R&D, NMPA has organized the formulation of the Guidelines for Real-World Evidence to Support Drug Development and Review (Interim), which has been released on January 7, 2020.